SBI Securities’s Day One Biopharmaceuticals DAWN Stock Holding History

SBI Securities’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60	Closed	-$1.29K	–	4109
2026 Q1	$1.29K	Sell	60 -21	-26%	-$296	﹤0.01%	2560
2025 Q4	$755	Hold	81	–	–	﹤0.01%	2735
2025 Q3	$571	Buy	81 +2	+3%	+$14	﹤0.01%	2915
2025 Q2	$514	Hold	79	–	–	﹤0.01%	2956
2025 Q1	$626	Hold	79	–	–	﹤0.01%	2775
2024 Q4	$1K	Buy	+79	New	+$1.1K	﹤0.01%	2606

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities's DAWN Position: Q2 2026 in Review

SBI Securities sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 60 shares — an estimated $1.29K sold.

SBI Securities first reported a position in DAWN in Q4 2024 and held it in 6 quarters. The position peaked at $1.29K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

SBI Securities reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 60 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.29K.
SBI Securities first reported a position in Day One Biopharmaceuticals in Q4 2024 and held it in 6 quarters.
SBI Securities's Day One Biopharmaceuticals position peaked at $1.29K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.